Literature DB >> 12689654

Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats.

Yoshinori Iba1, Yukio Sugimoto, Chiaki Kamei, Tohru Masukawa.   

Abstract

To clarify the role of mucosal mast cells in the lesion sites of colitis induced by dextran sulfate sodium (DSS) in rats, we investigated the histological changes and alterations relevant to mucosal mast cells in the spontaneous recovery process of colitis. Oral administration of 4% DSS solution for 11 days resulted in surface epithelial loss, crypt loss and goblet cell depletion in the rectal mucosa. A marked infiltration of inflammatory cells into the mucosa, which was consistent with a significant increase in myeloperoxidase (MPO) activity, was observed. In addition, mucosal mast cell number and rat mast cell protease (RMCP) I and II levels in the rectum increased at day 0 after DSS treatment, and most of the mucosal mast cells were degranulated. After replacing 4% DSS solution with water, re-epithelialization and restoration of goblet cells were observed at day 5 and day 10, respectively, but crypt damage was hardly recovered even at day 20. The elevated myeloperoxidase activity was significantly decreased from day 5 after DSS treatment. The increased number of mucosal mast cells was further elevated up to about 1.5-fold at day 10 and day 20 after DSS treatment and little degranulation was observed. In the spontaneous recovery process, the increased rat mast cell protease II level in the rectum was maintained for 20 days, while the increased rat mast cell protease I level was gradually decreased and recovered to control level. These results suggest that proliferated mucosal mast cells remained for 20 days, although most of infiltrated inflammatory cells disappeared in spontaneous recovery process of colitis. It may therefore be presumed that proliferated mucosal mast cells play a role in spontaneous recovery process of the colitis induced by DSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689654     DOI: 10.1016/S1567-5769(02)00299-0

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

1.  Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.

Authors:  Enzo Spisni; Maria C Valerii; Luigia De Fazio; Elena Cavazza; Francesca Borsetti; Annamaria Sgromo; Marco Candela; Manuela Centanni; Fernando Rizello; Antonio Strillacci
Journal:  Mol Ther       Date:  2014-11-13       Impact factor: 11.454

2.  Identification of histamine receptors and effects of histamine on murine and simian colonic excitability.

Authors:  H Kim; L Dwyer; J H Song; F E Martin-Cano; J Bahney; L Peri; F C Britton; K M Sanders; S D Koh
Journal:  Neurogastroenterol Motil       Date:  2011-08-01       Impact factor: 3.598

3.  Impact of basal diet on dextran sodium sulphate (DSS)-induced colitis in rats.

Authors:  Ahlem Boussenna; Nicolas Goncalves-Mendes; Juliette Joubert-Zakeyh; Bruno Pereira; Didier Fraisse; Marie-Paule Vasson; Odile Texier; Catherine Felgines
Journal:  Eur J Nutr       Date:  2014-11-20       Impact factor: 5.614

4.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Sodium arsenite reduces severity of dextran sulfate sodium-induced ulcerative colitis in rats.

Authors:  Joshua J Malago; Hortensia Nondoli
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

6.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

7.  Novel insights on the effect of nicotine in a murine colitis model.

Authors:  Shakir D AlSharari; Hamid I Akbarali; Rehab A Abdullah; Omer Shahab; Wimolnut Auttachoat; Gabriela A Ferreira; Kimber L White; Aron H Lichtman; Guy A Cabral; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-10-31       Impact factor: 4.030

8.  Sex Differences and Drug Dose Influence the Role of the α7 Nicotinic Acetylcholine Receptor in the Mouse Dextran Sodium Sulfate-Induced Colitis Model.

Authors:  Shakir D AlSharari; Deniz Bagdas; Hamid I Akbarali; Patraic A Lichtman; Erinn S Raborn; Guy A Cabral; F Ivy Carroll; Elizabeth A McGee; M Imad Damaj
Journal:  Nicotine Tob Res       Date:  2017-04-01       Impact factor: 4.244

9.  The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.

Authors:  Shakir D AlSharari; Wisam Toma; Hafiz M Mahmood; J Michael McIntosh; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2020-07-07       Impact factor: 5.195

10.  Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice.

Authors:  Antara Banerjee; Debora Bizzaro; Patrizia Burra; Rosa Di Liddo; Surajit Pathak; Diletta Arcidiacono; Andrea Cappon; Patrizio Bo; Maria Teresa Conconi; Marika Crescenzi; Claudia Maria Assunta Pinna; Pier Paolo Parnigotto; Malcolm R Alison; Giacomo Carlo Sturniolo; Renata D'Incà; Francesco Paolo Russo
Journal:  Stem Cell Res Ther       Date:  2015-04-16       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.